| Down‐regulation of hepatocyte nuclear factor‐4α and defective zonation in livers expressing mutant Z α1‐antitrypsin P Piccolo, P Annunziata, LR Soria, S Attanasio, A Barbato, R Castello, ... Hepatology 66 (1), 124-135, 2017 | 29 | 2017 |
| Activation of the c‐Jun N‐terminal kinase pathway aggravates proteotoxicity of hepatic mutant Z alpha1‐antitrypsin N Pastore, S Attanasio, B Granese, R Castello, J Teckman, AA Wilson, ... Hepatology 65 (6), 1865-1874, 2017 | 24 | 2017 |
| Up-regulation of miR-34b/c by JNK and FOXO3 protects from liver fibrosis P Piccolo, R Ferriero, A Barbato, S Attanasio, M Monti, C Perna, F Borel, ... Proceedings of the National Academy of Sciences 118 (10), e2025242118, 2021 | 19 | 2021 |
| CHOP and c-JUN up-regulate the mutant Z α1-antitrypsin, exacerbating its aggregation and liver proteotoxicity S Attanasio, R Ferriero, G Gernoux, R De Cegli, A Carissimo, E Nusco, ... Journal of Biological Chemistry 295 (38), 13213-13223, 2020 | 19 | 2020 |
| MIB2 variants altering NOTCH signalling result in left ventricle hypertrabeculation/non-compaction and are associated with Ménétrier-like gastropathy P Piccolo, S Attanasio, I Secco, R Sangermano, C Strisciuglio, ... Human Molecular Genetics 26 (1), 33-43, 2017 | 15 | 2017 |
| Microdeletion of pseudogene chr14.232.a affects LRFN5 expression in cells of a patient with autism spectrum disorder G Cappuccio, S Attanasio, M Alagia, M Mutarelli, R Borzone, M Karali, ... European Journal of Human Genetics 27 (9), 1475-1480, 2019 | 14 | 2019 |
| Hepatic glutamine synthetase augmentation enhances ammonia detoxification LR Soria, M Nitzahn, A De Angelis, S Khoja, S Attanasio, P Annunziata, ... Journal of inherited metabolic disease 42 (6), 1128-1135, 2019 | 13 | 2019 |
| O-GlcNAcylation enhances CPS1 catalytic efficiency for ammonia and promotes ureagenesis LR Soria, G Makris, AM D’Alessio, A De Angelis, I Boffa, VM Pravata, ... Nature Communications 13 (1), 5212, 2022 | 8 | 2022 |
| Mechanisms of liver disease P Piccolo, S Attanasio, N Brunetti-Pierri α1‑Antitrypsin deficiency (ERS mono‑graph). Sheffield: European Respiratory …, 2019 | 6 | 2019 |
| New mouse models with hypomorphic SUMF1 variants mimic attenuated forms of multiple sulfatase deficiency NC Sorrentino, M Presa, S Attanasio, V Cacace, M Sofia, A Zuberi, J Ryan, ... Journal of inherited metabolic disease 46 (2), 335-347, 2023 | 3 | 2023 |
| Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer A Cortesi, F Gandolfi, F Arco, P Di Chiaro, E Valli, S Polletti, R Noberini, ... Science Advances 10 (13), eadk5386, 2024 | | 2024 |
| Clonal dominance defines metastatic dissemination in pancreatic cancer IL Ho, CY Li, F Wang, L Zhao, J Liu, EY Yen, CA Dyke, R Shah, Z Liu, ... Science Advances 10 (11), eadd9342, 2024 | | 2024 |
| Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma N Thongon, F Ma, N Baran, P Lockyer, J Liu, C Jackson, A Rose, ... Nature Communications 15 (1), 1-13, 2024 | | 2024 |
| Abstract A011: DPY30 regulates immunoediting by suppressing uncoordinated DNA replication in pancreatic cancer F Citron, L Perelli, C Balestrieri, L Cecchetto, Y Chu, IL Ho, L Zhang, ... Cancer Research 84 (1_Supplement), A011-A011, 2024 | | 2024 |
| Uncovering key microenvironmental features for immunotherapy response at the subclonal level in pancreatic cancer EY Yen, IL Ho, CY Li, C Dyke, S Jiang, F Citron, S Attanasio, R Shah, ... Cancer Research 83 (7_Supplement), 5868-5868, 2023 | | 2023 |
| DPY30 loss leads to DNA re-replication and immunoediting in pancreatic ductal adenocarcinoma F Citron, L Perelli, Y Chu, S Srinivasan, IL Ho, EY Yen, R Shah, ... Cancer Research 83 (7_Supplement), 303-303, 2023 | | 2023 |
| AAV-Mediated Delivery of MiRNA-34B/C Improves Liver Fibrosis P Piccolo, R Ferriero, A Barbato, S Attanasio, M Monti, C Perna, F Borel, ... MOLECULAR THERAPY 29 (4), 17-17, 2021 | | 2021 |
| Alpha1-Antitrypsin Deficiency and c-JUN REPLY N Pastore, S Attanasio, N Brunetti-Pierri HEPATOLOGY 66 (2), 677-678, 2017 | | 2017 |
